J&J CEO Avoids Testimony in Philadelphia Risperdal Case
September 17, 2012
Chief executive Alex Gorsky was once proud enough of Risperdal to put its sales numbers on his resume, according to the Philadelphia Inquirer today, but Johnson & Johnson settled a case with a man who blamed the drug for causing him to grow breasts rather than risk Gorsky being forced to testify in person. The article does provide the link to a transcript of Gorsky’s deposition.
Article → Of further interest:
J&J Settles Risperdal Lawsuit on Opening Day of Trial
1 Boring Old Man blogs on this article
I have to say that I am saddened by how most people consider gynocomastia (male breasts) to be amongst the worst, if not the worst, “side effect” of neuroleptic drugs. I hardly ever hear people from the “norm” side of life get all upset over tardive dyskenisia, or what they call “tics”, or akathisia, that they call “anxiety”, but a teenage boy grows a pair of breasts? It’s an outrage. It in some ways allowed the CCHR to put up a stronghold in Florida because so many residents there were practically up in arms over it.
If I could choose because even the mildest case of tardive dyskenisia or even a temporary case of akathisia and a life time of male breasts, oh please, give me the breasts. At least the breasts wont torture you 24/7 for the rest of your life. At least male breasts are not a result of irreversible brain damage.
Report comment
Risperdal Legos!
This is Johnson and Johnson the ‘baby care people’ promoting dangerous Risperdal an atypical antipsychotic for Children.
Look HERE
http://medgadget.com/2007/05/risperdal_legos.html
Report comment